| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |